Breaking News

BioInvent Inks Mfg. Pact with Global Pharma Firm

Contract is valued at SEK 8 million

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioInvent International has signed an extended contract for manufacturing services with a top global pharmaceutical client for one of its development products. Product details and services were not disclosed. The new agreement is expected to generate about SEK 8 million in revenue, with the majority occurring in 2016. Michael Oredsson, president and chief executive officer of BioInvent, said, “We are pleased that we have been contracted to provide additional manufacturing services to this major...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters